Here is a short roundup of recent medical sales, medical device sales, medtech, pharma, and biotech headlines — useful context for reps, RSDs, and hiring teams watching the market.
Headlines worth watching
- 2026 Medical Device Industry M&A Roundup (Updated 8/4) (Medical Product Outsourcing): Merger and acquisition (M&A) transactions remain prevalent in the medical device manufacturing industry in all forms.
- KKR inks $5.7B deal to take medtech manufacturing giant Integer private (Fierce Biotech): The investment firm KKR expanded its healthcare portfolio with a $5.7 billion private, all-cash deal for medtech manufacturing giant Integer.
- KKR to take Integer private for $5.7B (MedTech Dive): Integer expects to gain flexibility and capital to invest in its contract development and manufacturing business under KKR.
- AdvaMed Strongly Supports Draft MDUFA VI Agreement at FDA Public Meeting (AdvaMed® - Advanced Medical Technology Association®): WASHINGTON, D.C.—AdvaMed, the Medtech Association, today expressed strong support for the draft Medical Device User Fee Amendments (MDUFA) VI agreement at...
- Johnson & Johnson postQ: Innovative Medicine lifts outlook; MedTech weak (S&P Global): Johnson & Johnson (NYSE: JNJ) beat Q2 expectations with strong Innovative Medicine gains and raised full-year guidance, but MedTech softness,...
Source links
2026 Medical Device Industry M&A Roundup (Updated 8/4)KKR inks $5.7B deal to take medtech manufacturing giant Integer privateKKR to take Integer private for $5.7BAdvaMed Strongly Supports Draft MDUFA VI Agreement at FDA Public MeetingJohnson & Johnson postQ: Innovative Medicine lifts outlook; MedTech weakWhat this means for medical sales careers
Product launches, clearances, and commercial expansion often show up first as hiring demand for territory managers, clinical specialists, and specialty sales roles. Use the headlines above as conversation starters — then verify openings and fit before you apply or post a role.